Songjiang Ma - 21 Mar 2025 Form 4 Insider Report for GYRE THERAPEUTICS, INC. (GYRE)

Signature
/s/ Songjiang Ma
Issuer symbol
GYRE
Transactions as of
21 Mar 2025
Net transactions value
-$1,740
Form type
4
Filing time
25 Mar 2025, 16:01:33 UTC
Previous filing
21 Mar 2025
Next filing
14 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GYRE Common Stock Sale $1,740 -174 -0.01% $10.00 2,824,844 21 Mar 2025 By Spouse F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2024.
F2 The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.005. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.